There are multiple clinical trials studying the role of vaccines in HCC alone and in combination with various therapies targeting peptides such as alpha-fetoprotein (AFP) (NCT 00005629), a marker normally found in fetal plasma and tested from maternal serum during pregnancy but erroneously secreted by certain HCC tumors with an unknown function [86]. The gene discussed is AFP; the disease is hepatocellular carcinoma.